Live News Categoriesmarket

CLRB.O (CLRB.O) News

Track canonical SquawkNews coverage tagged to CLRB.O, CLRB.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CLRB.O Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 11:32 AM UTC Open live news feed

M Cellectar Biosciences reports 79.2% major response rate in Phase 2 CLOVER-WaM iopofosine I 131 Cellectar said Phase 2 CLOVER-WaM subset results for iopofosine I 131 in BTK inhibitor-refractory Waldenström macroglobulinemia showed a 79.2% major response rate, with plans for a Phase 3 trial in early 2027 and a targe EARNINGS | Sep 29, 2026, 11:32 AM UTC